Audit Report for the audited financial result for the quarter and year ended on 31.03.2024 as per SEBI Circular dated July, 19, 2019
Awaiting price reaction for this filing.
Citurgia Biochemicals has submitted its audit report to BSE for the quarter and full year ended 31 March 2024, responding to a BSE query dated 15 April 2025. The report was filed by the auditor M/s G.P. Keshri & Associates under SEBI's prescribed format. The auditor issued an unqualified opinion, stating the results give a 'true and fair view' as required under Regulation 33 of the SEBI Listing Regulations. However, the auditor specifically references that the company reported a 'net loss' for both the quarter and the full year ended 31 March 2024. The audit report itself was signed on 22 May 2024, but the filing to BSE was made on 19 May 2025, indicating a significant delay in submission.
While the audit opinion is clean (unqualified), the explicit mention of a net loss means the company remained in the red for FY24. Shareholders should look out for the detailed financial numbers to assess the scale of the loss. The delayed filing to BSE may also raise governance concerns.